Low Incidence of GVHD with T-Cell Depleted Allografts Facilitate Further Treatments for Post-Transplantation Relapse in AML and MDS

Gelijkaardige items

• CD34+ selection vs. reduced-intensity conditioning and unmodified graft for allogeneic hematopoietic cell transplantation in patients with AML and MDS > 50 years
  door: Barba, Pere, et al.
  Gepubliceerd in: (2018)
• End-of-Life Care for Older AML Patients Relapsing after Allogeneic Stem Cell Transplant at a Dedicated Cancer Center
  door: Lin, Richard J., et al.
  Gepubliceerd in: (2018)
• Fludarabine-Melphalan Conditioning for AML and MDS: Alemtuzumab Reduces Acute and Chronic GVHD without Affecting Long-Term Outcomes
  door: Van Besien, Koen, et al.
  Gepubliceerd in: (2009)
• Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia, Normal Cytogenetics, and the FLT3-ITD Mutation
  door: Berman, Ellin, et al.
  Gepubliceerd in: (2015)
• Ex Vivo T Cell Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission
  door: Bayraktar, Ulas D., et al.
  Gepubliceerd in: (2013)